Compound information
- Natural Products
- ZC663146
- Molecular Formula
- C19H25N3O4S
- Molecular Weight
- 391.15657728 g/mol
- Structure
-
- IUPAC Name
- [4-(cyclopropanecarbonyl)piperazin-1-yl]-(4-pyrrolidin-1-ylsulfonylphenyl)methanone
- InChI
- InChI=1S/C19H25N3O4S/c23-18(15-3-4-15)20-11-13-21(14-12-20)19(24)16-5-7-17(8-6-16)27(25,26)22-9-1-2-10-22/h5-8,15H,1-4,9-14H2
- InChI Key
- ZZUYKZKXZFIRAW-UHFFFAOYSA-N
- SMILES
- O=C(c1ccc(S(=O)(=O)N2CCCC2)cc1)N1CCN(C(=O)C2CC2)CC1
- Source
- ZINC000008262690
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 27 | Ring Count | 4 |
Heteroatom Count | 8 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 78.0 Å2 | LogP | 0.718 |
LogS | -3.085 | LogD | 1.064 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.016 | Pgp substrate | 0.981 |
HIA | 0.971 | F20 % | 0.988 |
F30 % | 0.258 | Caco-2 | -4.7 |
MDCK | -4.992 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.56 | PPB | 87.853 |
VD | 0.694 | Fu | 0.776 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.009 | CYP1A2 substrate | 0.377 |
CYP2A6 substrate | 0.258 | CYP2B6 substrate | 0.675 |
CYP2C19 inhibitor | 0.304 | CYP2C19 substrate | 0.699 |
CYP2C8 substrate | 0.604 | CYP2C9 inhibitor | 0.326 |
CYP2C9 substrate | 0.427 | CYP2D6 inhibitor | 0.019 |
CYP2D6 substrate | 0.579 | CYP2E1 substrate | 0.274 |
CYP3A4 inhibitor | 0.029 | CYP3A4 substrate | 0.991 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.249 | CL | 2.343 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.018 | Hepatotoxicity | 0.582 |
Mutagenicity | 0.043 | Rat Oral Acute Toxicity | 0.659 |
FDAMDD | 0.456 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.058 | Eye Corrosion | 0.002 |
Eye Irritation | 0.004 | Respiratory Toxicity | 0.084 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.364 | IGC50 | 2.709 |
LC50FM | -18.572 | LC50DM | -3.083 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.326 | NR-AR-LBD | 0.311 |
NR-AhR | 0.081 | NR-Aromatase | 0.025 |
NR-ER | 0.333 | NR-ER-LBD | 0.452 |
NR-PPAR-gamma | 0.112 | SR-ARE | 0.511 |
SR-ATAD5 | 0.296 | SR-HSE | 0.119 |
SR-MMP | 0.012 | SR-p53 | 0.05 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.